Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
Harsha H Kariyawasam,1– 3 Louisa K James,4 Simon B Gane2,3 1Department of Specialist Allergy and Clinical Immunology, Royal National ENT Hospital, University College London Hospitals NHS Foundation Trust, London, UK; 2Department of Rhinology, Royal National ENT Hospital, University College...
Saved in:
Main Authors: | Kariyawasam HH (Author), James LK (Author), Gane SB (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
by: Kariyawasam HH, et al.
Published: (2020) -
Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
by: Kim J, et al.
Published: (2020) -
A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab
by: I. S. Krysanov, et al.
Published: (2021) -
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
by: Cosimo Galletti, et al.
Published: (2023) -
Predictive Values of Serum IL-33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps
by: Yanni Zhang, et al.
Published: (2022)